drugset / Trial / NCT02902133

Acetazolamide to Prevent Post Operative CSF Leak

NCT02902133

Phase 2 Withdrawn University of Miami
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research is to test the use of Acetazolamide in preventing post-operative cerebrospinal fluid leak in patients having endoscopic skull base surgery (it is a surgery performed through the nose and sinus).

Timeline

Start
2016-09-01
Primary completion
2021-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 500 mg Oral